Author:
Nespoli A.,Brivio F.,Fattori L.,Valerio M.,Nespoli L.,Arsena V.,Corso V.,Totis M.
Reference43 articles.
1. Menetrier-Caux C, Montmain G, Dieu MC, et al. Inhibition of the differentiation of dendritic cells from CD 34+ progenitors by tumour cells: role of interleukin 6 and macrophage colony-stimulating factors. Blood 1998; 92: 4778–4791
2. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. JExp Med 1982; 155: 1823–41
3. Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487–493
4. Bonfanti A, Lissoni P, Bucocev R, Rovelli F, Brivio F, Fumagalli L. Change in circulating Dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell carcinoma. Int J Biol Markers 2000; (15) 2: 161–164
5. Zhou D, Munster AM, Winchurch RA. Inhibitory effects of interleukin-6 on immunity. Arch Surg 1992; 127: 65–69